Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.31 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27525859 | 0.98 | KDM4E (0.38) | ALDH1A1TSHRKDM4ELMNAPAOX | |
| Acrylamide SCHEMBL9256321 | 0.87 | ALDH1A1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL492501 | 0.87 | CYP1A2 (0.41) | ALDH1A1TSHRKDM4ELMNAPAOX | |
| SCHEMBL11722825 | 0.85 | PAOX (0.48) | ALDH1A1TSHRKDM4ELMNAPAOX | |
| SCHEMBL182509 | 0.81 | ALDH1A1 (0.40) | ALDH1A1TSHRKDM4ELMNAMGAM | |
| SCHEMBL27821923 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TSHRMGAMGAASI | |
| SCHEMBL29232987 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TSHRMGAMGAASI | |
| SCHEMBL5861522 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TSHRMGAMGAASI | |
| SCHEMBL7064831 | 0.78 | CYP1A2 (0.45) | ALDH1A1TSHRLMNAMGAMGAA | |
| Ammonia Solution, Strong SCHEMBL6537990 | 0.77 | ALDH1A1 (0.37) | ALDH1A1TSHRMGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2023-03-30 | — | — | US | claimed |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | ORCA HOLDINGS, LLC | 2022-06-09 | — | — | US | claimed |
| EP-3997138-A1 | ACRYLIC POLYMER AND ADHESIVE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2022-05-18 | — | — | EP | claimed |
| US-20220133945-A1 | Acrylic Polymer and Adhesive Compositions | HENKEL AG & CO. KGAA (DE) | 2022-05-05 | — | — | US | claimed |
| EP-3938359-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2022-01-19 | — | — | EP | claimed |
| WO-2021007584-A1 | ACRYLIC POLYMER AND ADHESIVE COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2021-01-14 | — | — | WO | claimed |
| WO-2020186077-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | 6th Wave Innovations Corp. (US) | 2020-09-17 | — | — | WO | claimed |
| CN-105985749-B | UV solidifies liquid optical cement and the preparation method and application thereof | 东莞市派乐玛新材料技术开发有限公司 | 2019-06-28 | — | — | CN | claimed |
| CN-108778259-A | The transmucosal film of montelukast | 因特根克斯公司 | 2018-11-09 | — | — | CN | claimed |
| CN-107690494-A | CATIONIC POLYMER THICKENERS | S.P.C.M.股份公司 | 2018-02-13 | — | — | CN | claimed |
| WO-1999009947-A1 | CLEANSING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-04 | — | — | WO | claimed |
| WO-1999009948-A1 | CLEANSING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1999-03-04 | — | — | WO | claimed |
| US-5454841-A | Compositions and method for temporarily coloring hair using a complex of water soluble melanin and a cationic material | CLAIROL, INC. (US) | 1995-10-03 | — | — | US | claimed |
| US-5319400-A | Light-blocking transparency assembly | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-06-07 | — | — | US | claimed |
| US-5310595-A | Multilayer element with radiation transparent backing on paper and toner receptive coating of (meth)acrylate copolymers | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-05-10 | — | — | US | claimed |
| EP-0567835-A1 | Electrically conductive abrasion resistant polymeric materials, their fabrication and uses thereof | International Business Machines Corporation (US) | 1993-11-03 | — | — | EP | claimed |
| EP-0156369-B1 | TONERS TREATED WITH POLYMERIC QUATERNARY AMMONIUM SALTS AND SLIP AGENT AND PROCESS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-12-05 | — | — | EP | claimed |
| EP-0238723-A2 | Method of rapidly dissolving polymer gels in water | Diatec Polymers doing business as Diatec Environmental (US) | 1987-09-30 | — | — | EP | claimed |
| US-4546072-A | Toners treated with polymeric quaternary ammonium salts and slip agent | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-10-08 | — | — | US | claimed |
| EP-0156369-A2 | Toners treated with polymeric quaternary ammonium salts and slip agent and process | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-10-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230100363-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | ALDH1A1 3487/4885TSHR 4448/4885KDM4E 139/4885 |
| US-20220177666-A1 | MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF | CNR2, CNR1, CDIPT | ALDH1A1 3487/4885TSHR 4448/4885KDM4E 139/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.